All companies › VCYT

VCYT · VERACYTE, INC.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells13
Research cases0
Last filing2026-10-27

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-01 — Bhanji Muna · sold 1,864 @ $42.97 2026-09-04 — McGuire Annie · sold 2,154 @ $42.79 2026-09-04 — McGuire Annie · sold 1,100 @ $43.67 2026-09-04 — Febbo Phillip G. · sold 10,405 @ $42.89 2026-09-04 — Febbo Phillip G. · sold 2,705 @ $43.66 2026-09-04 — Chambers Rebecca · sold 2,477 @ $42.81 2026-09-04 — Chambers Rebecca · sold 1,175 @ $43.71 2026-09-14 — Holstein Jens · sold 5,000 @ $40.95 2026-09-21 — Leite John · sold 4,015 @ $40.00 2026-09-24 — Holstein Jens · sold 7,500 @ $47.00 2026-10-19 — Bhanji Muna · sold 1,864 @ $43.70 2026-10-27 — EASTHAM KARIN · sold 14,850 @ $50.00 2026-10-27 — Holstein Jens · sold 7,500 @ $50.00
2026-09-012026-10-27

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Holstein Jens Director
Bhanji Muna Director
McGuire Annie EVP, General Counsel
Febbo Phillip G. Chief Scientific & Med Officer
Chambers Rebecca Chief Financial Officer
Leite John Global Chief Commercial Off
EASTHAM KARIN Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $VCYT is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-27', 'insider_name': 'EASTHAM KARIN', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 14850.0, 'price': 50.0049, 'value': 742572.77, 'is_buy': False}, {'transaction_date': '2026-10-27', 'insider_name': 'Holstein Jens', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 7500.0, 'price': 50.0, 'value': 375000.0, 'is_buy': False}, {'transaction_date': '2026-10-19', 'insider_name': 'Bhanji Muna', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1864.0, 'price': 43.7, 'value': 81456.8, 'is_buy': False}, {'transaction_date': '2026-09-24', 'insider_name': 'Holstein Jens', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 7500.0, 'price': 47.0, 'value': 352500.0, 'is_buy': False}, {'transaction_date': '2026-09-21', 'insider_name': 'Leite John', 'insider_title': 'Global Chief Commercial Off', 'transaction_type': 'Open-market sell', 'shares': 4015.0, 'price': 40.0, 'value': 160600.0, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'Holstein Jens', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 5000.0, 'price': 40.95, 'value': 204750.0, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'McGuire Annie', 'insider_title': 'EVP, General Counsel', 'transaction_type': 'Open-market sell', 'shares': 2154.0, 'price': 42.7916, 'value': 92173.11, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'McGuire Annie', 'insider_title': 'EVP, General Counsel', 'transaction_type': 'Open-market sell', 'shares': 1100.0, 'price': 43.6718, 'value': 48038.98, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Febbo Phillip G.', 'insider_title': 'Chief Scientific & Med Officer', 'transaction_type': 'Open-market sell', 'shares': 10405.0, 'price': 42.8933, 'value': 446304.79, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Febbo Phillip G.', 'insider_title': 'Chief Scientific & Med Officer', 'transaction_type': 'Open-market sell', 'shares': 2705.0, 'price': 43.6618, 'value': 118105.17, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Chambers Rebecca', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 2477.0, 'price': 42.8059, 'value': 106030.21, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Chambers Rebecca', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 1175.0, 'price': 43.714, 'value': 51363.95, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Bhanji Muna', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1864.0, 'price': 42.97, 'value': 80096.08, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for VCYT today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.